ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,072	957.8	726.44	517.24	484.15
Revenue Growth (YoY)	11.87%	31.85%	40.45%	6.83%	9.60%
Cost of Revenue	89	81.84	41.64	10.17	19.14
Gross Profit	982.51	875.96	684.8	507.07	465
Selling, General & Admin	548.89	488.43	406.56	369.09	396.03
Research & Development	328.8	303.25	351.62	361.58	239.42
Other Operating Expenses	-	-146.52	-	-	-
Total Operating Expenses	877.7	645.16	758.18	730.67	635.44
Operating Income	104.81	230.79	-73.38	-223.6	-170.44
Interest Income	31.72	25.46	17.23	6.61	0.59
Other Non-Operating Income (Expense)	2.37	1.82	5.11	3.54	2.33
Total Non-Operating Income (Expense)	34.09	27.28	22.34	10.15	2.92
Pretax Income	138.9	258.08	-51.04	-213.44	-167.52
Provision for Income Taxes	-252.1	31.62	10.25	2.53	0.35
Net Income	391	226.45	-61.29	-215.98	-167.87
Net Income to Common	391	226.45	-61.29	-215.98	-167.87
Net Income Growth	72.66%	-	-	-	-
Shares Outstanding (Basic)	168	166	164	162	160
Shares Outstanding (Diluted)	170	166	164	162	160
Shares Change (YoY)	2.14%	1.55%	1.32%	0.74%	2.01%
EPS (Basic)	2.32	1.37	-0.37	-1.34	-1.05
EPS (Diluted)	2.30	1.36	-0.37	-1.34	-1.05
EPS Growth	69.12%	-	-	-	-
Free Cash Flow	105.15	157.2	16.65	-114.04	-126.78
Free Cash Flow Growth	-33.11%	844.01%	-	-	-
Free Cash Flow Per Share	0.62	0.94	0.10	-0.71	-0.79
Gross Margin	91.69%	91.46%	94.27%	98.03%	96.05%
Operating Margin	9.78%	24.10%	-10.10%	-43.23%	-35.20%
Profit Margin	36.49%	23.64%	-8.44%	-41.76%	-34.67%
FCF Margin	9.81%	16.41%	2.29%	-22.05%	-26.19%
EBITDA	116.57	246.68	-67.83	-223.6	-167.1
EBITDA Margin	10.88%	25.75%	-9.34%	-43.23%	-34.51%
EBIT	104.81	230.79	-73.38	-223.6	-170.44
EBIT Margin	9.78%	24.10%	-10.10%	-43.23%	-35.20%
Effective Tax Rate	-181.49%	12.25%	-20.08%	-1.19%	-0.21%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q